Intestinal epithelial CD98 directly modulates the innate host response to enteric bacterial pathogens

Infection and Immunity

Volumn 81, Issue 3, 2013, Pages 923-934

  Charania, Moiz A ^a   Laroui, Hamed ^a   Liu, Hongchun ^c,d   Viennois, Emilie ^a   Ayyadurai, Saravanan ^a   Xiao, Bo ^a   Ingersoll, Sarah A ^a,b   Kalman, Daniel ^c   Merlin, Didier ^a,b  

^a GEORGIA STATE UNIVERSITY   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTEGRIN; CD98 ANTIGEN; CYCLIN D1; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 6; KI 67 ANTIGEN; MESSENGER RNA; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL COLONIZATION; CELL ADHESION; CELL PROLIFERATION; CELL STRAIN CACO 2; CELLULAR DISTRIBUTION; CITROBACTER RODENTIUM; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; EX VIVO STUDY; GENE OVEREXPRESSION; GENE SILENCING; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; INTESTINE EPITHELIUM CELL; INTESTINE INFECTION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURFACE PLASMON RESONANCE;

ANIMALS; ANTIGENS, CD98; CACO-2 CELLS; CITROBACTER RODENTIUM; COLON; ENTEROBACTERIACEAE INFECTIONS; ENTEROPATHOGENIC ESCHERICHIA COLI; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; INTESTINAL MUCOSA; MALE; MICE; MICE, TRANSGENIC; PEROXIDASE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84874743026     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01388-12     Document Type: Article

References (48)

1. Danielsen EM, Hansen GH. 2008. Lipid raft organization and function in the small intestinal brush border. J. Physiol. Biochem. 64:377-382.
2. Izumi Y, Hirose T, Tamai Y, Hirai S, Nagashima Y, Fujimoto T, Tabuse Y, Kemphues KJ, Ohno S. 1998. An atypical PKC directly associates and colocalizes at the epithelial tight junction with ASIP, a mammalian homologue of Caenorhabditis elegans polarity protein PAR-3. J. Cell Biol. 143: 95-106.
3. Baas AF, Kuipers J, van der Wel NN, Batlle E, Koerten HK, Peters PJ, Clevers HC. 2004. Complete polarization of single intestinal epithelial cells upon activation of LKB1 by STRAD. Cell 116:457-466.
4. Man Y, Hart VJ, Ring CJ, Sanjar S, West MR. 2000. Loss of epithelial integrity resulting from E-cadherin dysfunction predisposes airway epithelial cells to adenoviral infection. Am. J. Respir. Cell Mol. Biol. 23:610-617.
5. Fujimori T, Takeichi M. 1993. Disruption of epithelial cell-cell adhesion by exogenous expression of a mutated nonfunctional N-cadherin. Mol. Biol. Cell 4:37-47.
6. Troxell ML, Gopalakrishnan S, McCormack J, Poteat BA, Pennington J, Garringer SM, Schneeberger EE, Nelson WJ, Marrs JA. 2000. Inhibiting cadherin function by dominant mutant E-cadherin expression increases the extent of tight junction assembly. J. Cell Sci. 113:985-996.
7. Nava P, Lopez S, Arias CF, Islas S, Gonzalez-Mariscal L. 2004. The rotavirus surface protein VP8 modulates the gate and fence function of tight junctions in epithelial cells. J. Cell Sci. 117:5509-5519.
8. Beau I, Cotte-Laffitte J, Amsellem R, Servin AL. 2007. A protein kinase A-dependent mechanism by which rotavirus affects the distribution and mRNA level of the functional tight junction-associated protein, occludin, in human differentiated intestinal Caco-2 cells. J. Virol. 81:8579-8586.
9. Evans MJ, von Hahn T, Tscherne DM, Syder AJ, Panis M, Wolk B, Hatziioannou T, McKeating JA, Bieniasz PD, Rice CM. 2007. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446:801-805.
10. Kerr JR. 1999. Cell adhesion molecules in the pathogenesis of and host defence against microbial infection. Mol. Pathol. 52:220-230.
11. Knodler LA, Celli J, Finlay BB. 2001. Pathogenic trickery: deception of host cell processes. Nat. Rev. Mol. Cell Biol. 2:578-588.
12. Chen HD, Frankel G. 2005. Enteropathogenic Escherichia coli: unravelling pathogenesis. FEMS Microbiol. Rev. 29:83-98.
13. Miyake M, Hanajima M, Matsuzawa T, Kobayashi C, Minami M, Abe A, Horiguchi Y. 2005. Binding of intimin with Tir on the bacterial surface is prerequisite for the barrier disruption induced by enteropathogenic Escherichia coli. Biochem. Biophys. Res. Commun. 337:922-927.
14. Guttman JA, Finlay BB. 2009. Tight junctions as targets of infectious agents. Biochim. Biophys. Acta 1788:832-841.
15. Knutton S, Rosenshine I, Pallen MJ, Nisan I, Neves BC, Bain C, Wolff C, Dougan G, Frankel G. 1998. A novel EspA-associated surface organelle of enteropathogenic Escherichia coli involved in protein translocation into epithelial cells. EMBO J. 17:2166-2176.
16. Kenny B, DeVinney R, Stein M, Reinscheid DJ, Frey EA, Finlay BB. 1997. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91:511-520.
17. Sekiya K, Ohishi M, Ogino T, Tamano K, Sasakawa C, Abe A. 2001. Supermolecular structure of the enteropathogenic Escherichia coli type III secretion system and its direct interaction with the EspA-sheath-like structure. Proc. Natl. Acad. Sci. U. S. A. 98:11638-11643.
18. Wachter C, Beinke C, Mattes M, Schmidt MA. 1999. Insertion of EspD into epithelial target cell membranes by infecting enteropathogenic Escherichia coli. Mol. Microbiol. 31:1695-1707.
19. Frankel G, Lider O, Hershkoviz R, Mould AP, Kachalsky SG, Candy DC, Cahalon L, Humphries MJ, Dougan G. 1996. The cell-binding domain of intimin from enteropathogenic Escherichia coli binds to beta1 integrins. J. Biol. Chem. 271:20359-20364.
20. Muza-Moons MM, Koutsouris A, Hecht G. 2003. Disruption of cell polarity by enteropathogenic Escherichia coli enables basolateral membrane proteins to migrate apically and to potentiate physiological consequences. Infect. Immun. 71:7069-7078.
21. Kucharzik T, Lugering A, Yan Y, Driss A, Charrier L, Sitaraman S, Merlin D. 2005. Activation of epithelial CD98 glycoprotein perpetuates colonic inflammation. Lab. Invest. 85:932-941.
22. Nguyen HT, Dalmasso G, Yan Y, Laroui H, Dahan S, Mayer L, Sitaraman SV, Merlin D. 2010. MicroRNA-7 modulates CD98 expression during intestinal epithelial cell differentiation. J. Biol. Chem. 285:1479-1489.
23. Yan Y, Dalmasso G, Sitaraman S, Merlin D. 2007. Characterization of the human intestinal CD98 promoter and its regulation by interferongamma. Am. J. Physiol. Gastrointest. Liver Physiol. 292:G535-545.
24. Charania MA, Ayyadurai S, Ingersoll SA, Xiao B, Viennois E, Yan Y, Laroui H, Sitaraman SV, Merlin D. 2012. Intestinal epithelial CD98 synthesis specifically modulates expression of colonic microRNAs during colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 302:G1282-G1291.
25. Chandrasekaran S, Guo NH, Rodrigues RG, Kaiser J, Roberts DD. 1999. Pro-adhesive and chemotactic activities of thrombospondin-1 for breast carcinoma cells are mediated by alpha3beta1 integrin and regulated by insulin-like growth factor-1 and CD98. J. Biol. Chem. 274:11408-11416.
26. Fenczik CA, Sethi T, Ramos JW, Hughes PE, Ginsberg MH. 1997. Complementation of dominant suppression implicates CD98 in integrin activation. Nature 390:81-85.
27. Fenczik CA, Zent R, Dellos M, Calderwood DA, Satriano J, Kelly C, Ginsberg MH. 2001. Distinct domains of CD98hc regulate integrins and amino acid transport. J. Biol. Chem. 276:8746-8752.
28. Feral CC, Nishiya N, Fenczik CA, Stuhlmann H, Slepak M, Ginsberg MH. 2005. CD98hc (SLC3A2) mediates integrin signaling. Proc. Natl. Acad. Sci. U. S. A. 102:355-360.
29. Henderson NC, Collis EA, Mackinnon AC, Simpson KJ, Haslett C, Zent R, Ginsberg M, Sethi T. 2004. CD98hc (SLC3A2) interaction with beta 1 integrins is required for transformation. J. Biol. Chem. 279:54731-54741.
30. Kolesnikova TV, Mannion BA, Berditchevski F, Hemler ME. 2001. Beta1 integrins show specific association with CD98 protein in low density membranes. BMC Biochem. 2:10. doi:10.1186/1471-2091-2-10.
31. Liu S, Calderwood DA, Ginsberg MH. 2000. Integrin cytoplasmic domain- binding proteins. J. Cell Sci. 113:3563-3571.
32. Zent R, Fenczik CA, Calderwood DA, Liu S, Dellos M, Ginsberg MH. 2000. Class- and splice variant-specific association of CD98 with integrin beta cytoplasmic domains. J. Biol. Chem. 275:5059-5064.
33. Merlin D, Sitaraman S, Liu X, Eastburn K, Sun J, Kucharzik T, Lewis B, Madara JL. 2001. CD98-mediated links between amino acid transport and beta 1 integrin distribution in polarized columnar epithelia. J. Biol. Chem. 276:39282-39289.
34. Shames SR, Deng W, Guttman JA, de Hoog CL, Li Y, Hardwidge PR, Sham HP, Vallance BA, Foster LJ, Finlay BB. 2010. The pathogenic E. coli type III effector EspZ interacts with host CD98 and facilitates host cell prosurvival signalling. Cell. Microbiol. 12:1322-1339.
35. Nguyen HT, Dalmasso G, Torkvist L, Halfvarson J, Yan Y, Laroui H, Shmerling D, Tallone T, D'Amato M, Sitaraman SV, Merlin D. 2011. CD98 expression modulates intestinal homeostasis, inflammation, and colitis-associated cancer in mice. J. Clin. Invest. 121:1733-1747.
36. Nguyen HT, Dalmasso G, Powell KR, Yan Y, Bhatt S, Kalman D, Sitaraman SV, Merlin D. 2009. Pathogenic bacteria induce colonic PepT1 expression: an implication in host defense response. Gastroenterology 137:1435-1447.
37. Yao X, Li X, Toledo F, Zurita-Lopez C, Gutova M, Momand J, Zhou F. 2006. Sub-attomole oligonucleotide and p53 cDNA determinations via a high-resolution surface plasmon resonance combined with oligonucleotide- capped gold nanoparticle signal amplification. Anal. Biochem. 354: 220-228.
38. Mundy R, MacDonald TT, Dougan G, Frankel G, Wiles S. 2005. Citrobacter rodentium of mice and man. Cell. Microbiol. 7:1697-1706.
39. Rodrigues DM, Sousa AJ, Johnson-Henry KC, Sherman PM, Gareau MG. 2012. Probiotics are effective for the prevention and treatment of Citrobacter rodentium-induced colitis in mice. J. Infect. Dis. 206:99-109.
40. Luperchio SA, Schauer DB. 2001. Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia. Microbes Infect. 3:333-340.
41. Cai S, Bulus N, Fonseca-Siesser PM, Chen D, Hanks SK, Pozzi A, Zent R. 2005. CD98 modulates integrin beta1 function in polarized epithelial cells. J. Cell Sci. 118:889-899.
42. Torreri P, Ceccarini M, Macioce P, Petrucci TC. 2005. Biomolecular interactions by surface plasmon resonance technology. Ann. Ist. Super. Sanita 41:437-441.
43. Dann SM, Spehlmann ME, Hammond DC, Iimura M, Hase K, Choi LJ, Hanson E, Eckmann L. 2008. IL-6-dependent mucosal protection prevents establishment of a microbial niche for attaching/effacing lesionforming enteric bacterial pathogens. J. Immunol. 180:6816-6826.
44. Geddes K, Rubino SJ, Magalhaes JG, Streutker C, Le Bourhis L, Cho JH, Robertson SJ, Kim CJ, Kaul R, Philpott DJ, Girardin SE. 2011. Identification of an innate T helper type 17 response to intestinal bacterial pathogens. Nat. Med. 17:837-844.
45. Cantor JM, Ginsberg MH, Rose DM. 2008. Integrin-associated proteins as potential therapeutic targets. Immunol. Rev. 223:236-251.
46. Nguyen HT, Dalmasso G, Yan Y, Obertone TS, Sitaraman SV, Merlin D. 2008. Ecto-phosphorylation of CD98 regulates cell-cell interactions. PLoS One 3:e3895. doi:10.1371/journal.pone.0003895.
47. Sato Y, Heimeier RA, Li C, Deng C, Shi YB. 2011. Extracellular domain of CD98hc is required for early murine development. Cell Biosci. 1:7. doi: 10.1186/2045-3701-1-7.
48. Yan Y, Vasudevan S, Nguyen H, Bork U, Sitaraman S, Merlin D. 2007. Extracellular interaction between hCD98 and the PDZ class II domain of hCASK in intestinal epithelia. J. Membr. Biol. 215:15-26.